Vimian names Hans Lord Skarplöth head of Specialty Pharma from Oct. 1

Reuters2026/08/27 05:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Vimian appointed Hans Lord Skarplöth as head of Specialty Pharma, joining the group management team from Oct. 1, 2026.
Skarplöth previously served 13 years as CEO of ATG, leading a transformation focused on market position, international expansion, new launches.
He earlier held senior leadership roles within the Kinnevik sphere for more than seven years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vimian Group AB published the original content used to generate this news brief on August 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Vimian names Hans Lord Skarplöth head of Specialty Pharma from Oct. 1

You may also like

Crypto prices